A next-generation sequencing result is generally reported in one of three ways: a genetic cause was clearly identified and explains the person’s symptoms; one or more variants of uncertain significance were found, meaning a change exists but its significance is not yet clear; or no relevant genetic change was identified in the genes or regions examined. What happens next depends on which of these applies:

• When a clear genetic cause is found, a geneticist or genetic counselor explains what the finding means for the person’s health, connects the family with any relevant specialists, and discusses the chance of the condition occurring again in future pregnancies or affecting other relatives.
• When a variant of uncertain significance is found, testing close relatives can sometimes help clarify whether the change is likely to be significant, and the finding is generally not used alone to make major medical decisions until more is known.
• When no answer is found, options often include periodic reanalysis of the existing data as scientific knowledge improves, moving from a gene panel to whole exome or whole genome sequencing if a narrower test was tried first, or considering chromosomal microarray if it was not already performed, since it can catch certain changes that sequencing is not designed to see.
• When secondary findings were requested and identified, families are connected with the relevant specialists for that specific condition, separate from the original reason testing was pursued.

Next-generation sequencing, including gene panels, whole exome sequencing, and whole genome sequencing, is increasingly available in India through accredited diagnostic and genetics laboratories, and the Indian Academy of Medical Genetics has published specific guidance for its use in Indian clinical practice. This guidance emphasizes that whole exome sequencing has become a reasonable first-tier test for conditions caused by changes within single genes, while gene panels remain appropriate where the number of genes that could be responsible is more limited. It also stresses that responsible use of this testing depends on early referral to a clinical geneticist, thorough pre-test counseling covering what the test can and cannot answer, and interpretation by laboratories with the training and standards needed to correctly classify what is often a large and complex set of results, since the breadth of information this test can return is only as useful as the expertise available to interpret it. Families are encouraged to confirm that a laboratory holds appropriate accreditation and that genetic counseling, both before and after testing, is included as a standard part of the process.